BACKGROUND: Despite years of intense focus, inpatient and observation readmission rates remain high and largely unchanged. Hospitals have little, robust evidence to guide the selection of interventions effective at reducing 30-day readmissions in real-world settings. OBJECTIVE: To evaluate if implementation of recent recommendations for hospital transition programs is effective at reducing 30-day readmissions in a population discharged to home and at high-risk for readmission. DESIGN: A non-blinded, pragmatic randomized controlled trial ( Clinicaltrials.gov : NCT02763202) conducted at two hospitals in Charlotte, North Carolina. PATIENTS: A total of 1876 adult patients, under the care of a hospitalist, and at high risk for readmissions. INTERVENTION: Random allocation to a Transition Services (TS) program (n = 935) that bridges inpatient, outpatient, and home settings, providing patients virtual and in-person access to a dedicated multidisciplinary team for 30-days, or usual care (n = 941). MAIN MEASURE: Thirty-day, unplanned, inpatient, or observation readmission rate. KEY RESULTS: The 30-day readmission rate was 15.2% in the TS group and 16.3% in the usual care group (RR 0.93; 95% [CI, 0.76 to 1.15]; P = 0.52). There were no significant differences in readmissions at 60 and 90 days or in 30-day Emergency Department visit rates. Patients, who were referred to TS and readmitted, had less Intensive Care Unit admissions 15.5% vs. 26.8% (RR 0.74; 95% [CI, 0.59 to 0.93]; P = 0.02). CONCLUSIONS: An intervention inclusive of contemporary recommendations does not reduce a high-risk population's 30-day readmission rate. The high crossover to usual care (74.8%) reflects the challenge of non-participation that is ubiquitous in the real-world implementation of population health interventions. TRIAL REGISTRY: ClinicalTrials.gov ; registration ID number: NCT02763202, URL: https://clinicaltrials.gov/ct2/show/NCT02763202.
RCT Entities:
BACKGROUND: Despite years of intense focus, inpatient and observation readmission rates remain high and largely unchanged. Hospitals have little, robust evidence to guide the selection of interventions effective at reducing 30-day readmissions in real-world settings. OBJECTIVE: To evaluate if implementation of recent recommendations for hospital transition programs is effective at reducing 30-day readmissions in a population discharged to home and at high-risk for readmission. DESIGN: A non-blinded, pragmatic randomized controlled trial ( Clinicaltrials.gov : NCT02763202) conducted at two hospitals in Charlotte, North Carolina. PATIENTS: A total of 1876 adult patients, under the care of a hospitalist, and at high risk for readmissions. INTERVENTION: Random allocation to a Transition Services (TS) program (n = 935) that bridges inpatient, outpatient, and home settings, providing patients virtual and in-person access to a dedicated multidisciplinary team for 30-days, or usual care (n = 941). MAIN MEASURE: Thirty-day, unplanned, inpatient, or observation readmission rate. KEY RESULTS: The 30-day readmission rate was 15.2% in the TS group and 16.3% in the usual care group (RR 0.93; 95% [CI, 0.76 to 1.15]; P = 0.52). There were no significant differences in readmissions at 60 and 90 days or in 30-day Emergency Department visit rates. Patients, who were referred to TS and readmitted, had less Intensive Care Unit admissions 15.5% vs. 26.8% (RR 0.74; 95% [CI, 0.59 to 0.93]; P = 0.02). CONCLUSIONS: An intervention inclusive of contemporary recommendations does not reduce a high-risk population's 30-day readmission rate. The high crossover to usual care (74.8%) reflects the challenge of non-participation that is ubiquitous in the real-world implementation of population health interventions. TRIAL REGISTRY: ClinicalTrials.gov ; registration ID number: NCT02763202, URL: https://clinicaltrials.gov/ct2/show/NCT02763202.
Entities:
Keywords:
healthcare value; outcomes research; population health; pragmatic research; readmissions
Authors: Kevin E Thorpe; Merrick Zwarenstein; Andrew D Oxman; Shaun Treweek; Curt D Furberg; Douglas G Altman; Sean Tunis; Eduardo Bergel; Ian Harvey; David J Magid; Kalipso Chalkidou Journal: CMAJ Date: 2009-04-16 Impact factor: 8.262
Authors: Rachael B Zuckerman; Steven H Sheingold; E John Orav; Joel Ruhter; Arnold M Epstein Journal: N Engl J Med Date: 2016-02-24 Impact factor: 91.245
Authors: Brian W Jack; Veerappa K Chetty; David Anthony; Jeffrey L Greenwald; Gail M Sanchez; Anna E Johnson; Shaula R Forsythe; Julie K O'Donnell; Michael K Paasche-Orlow; Christopher Manasseh; Stephen Martin; Larry Culpepper Journal: Ann Intern Med Date: 2009-02-03 Impact factor: 25.391
Authors: Gideon A Caplan; Nur S Sulaiman; Dee A Mangin; Nicoletta Aimonino Ricauda; Andrew D Wilson; Louise Barclay Journal: Med J Aust Date: 2012-11-05 Impact factor: 7.738
Authors: Stephanie Rennke; Oanh K Nguyen; Marwa H Shoeb; Yimdriuska Magan; Robert M Wachter; Sumant R Ranji Journal: Ann Intern Med Date: 2013-03-05 Impact factor: 25.391
Authors: Lian Leng Low; Shu Yun Tan; Matthew Joo Ming Ng; Wei Yi Tay; Lee Beng Ng; Kanchana Balasubramaniam; Rachel Marie Towle; Kheng Hock Lee Journal: PLoS One Date: 2017-01-03 Impact factor: 3.240
Authors: Paul Y Takahashi; Anupam Chandra; Rozalina G McCoy; Lynn S Borkenhagen; Mary E Larson; Bjorg Thorsteinsdottir; Joel A Hickman; Kristi M Swanson; Gregory J Hanson; James M Naessens Journal: J Am Med Dir Assoc Date: 2021-05-11 Impact factor: 4.669
Authors: Anita D Misra-Hebert; Michael B Rothberg; Jaqueline Fox; Xinge Ji; Bo Hu; Alex Milinovich; William Zafirau; Anthony Onuzuruike; Kurt C Stange Journal: Healthc (Amst) Date: 2021-01-04
Authors: Marc Kowalkowski; Tara Eaton; Andrew McWilliams; Hazel Tapp; Aleta Rios; Stephanie Murphy; Ryan Burns; Bella Gutnik; Katherine O'Hare; Lewis McCurdy; Michael Dulin; Christopher Blanchette; Shih-Hsiung Chou; Scott Halpern; Derek C Angus; Stephanie P Taylor Journal: BMC Health Serv Res Date: 2021-06-02 Impact factor: 2.655
Authors: Evelyn T Chang; Jean Yoon; Aryan Esmaeili; Donna M Zulman; Michael K Ong; Susan E Stockdale; Elvira E Jimenez; Karen Chu; David Atkins; Angela Denietolis; Steven M Asch Journal: Health Serv Res Date: 2021-06-18 Impact factor: 3.734
Authors: Marc Kowalkowski; Shih-Hsiung Chou; Andrew McWilliams; Cathryn Lashley; Stephanie Murphy; Whitney Rossman; Alfred Papali; Alan Heffner; Mark Russo; Larry Burke; Michael Gibbs; Stephanie P Taylor Journal: Trials Date: 2019-11-29 Impact factor: 2.279
Authors: Kranthi Sitammagari; Stephanie Murphy; Marc Kowalkowski; Shih-Hsiung Chou; Matthew Sullivan; Stephanie Taylor; James Kearns; Thomas Batchelor; Carly Rivet; Colleen Hole; Tony Hinson; Pamela McCreary; Ryan Brown; Todd Dunn; Zeev Neuwirth; Andrew McWilliams Journal: Ann Intern Med Date: 2020-11-11 Impact factor: 25.391